de Miguel, L.; Ballester, P.; Egoavil, C.; Sánchez-Ocaña, M.L.; GarcÃa-Muñoz, A.M.; Cerdá, B.; Zafrilla, P.; Ramos, E.; Peiró, A.M.
Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study. Pharmaceuticals 2023, 16, 1496.
https://doi.org/10.3390/ph16101496
AMA Style
de Miguel L, Ballester P, Egoavil C, Sánchez-Ocaña ML, GarcÃa-Muñoz AM, Cerdá B, Zafrilla P, Ramos E, Peiró AM.
Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study. Pharmaceuticals. 2023; 16(10):1496.
https://doi.org/10.3390/ph16101496
Chicago/Turabian Style
de Miguel, Laura, Pura Ballester, Cecilia Egoavil, MarÃa Luisa Sánchez-Ocaña, Ana MarÃa GarcÃa-Muñoz, Begoña Cerdá, Pilar Zafrilla, Enrique Ramos, and Ana M. Peiró.
2023. "Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study" Pharmaceuticals 16, no. 10: 1496.
https://doi.org/10.3390/ph16101496
APA Style
de Miguel, L., Ballester, P., Egoavil, C., Sánchez-Ocaña, M. L., GarcÃa-Muñoz, A. M., Cerdá, B., Zafrilla, P., Ramos, E., & Peiró, A. M.
(2023). Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study. Pharmaceuticals, 16(10), 1496.
https://doi.org/10.3390/ph16101496
